Using "rationally designed drugs" rationally

被引：4

作者：

Brugarolas, J ^{[1
]}

Clark, JW

Chabner, B

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

来源：

LANCET | 2003年 / 361卷 / 9371期

关键词：

D O I：

10.1016/S0140-6736(03)13446-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1758 / 1759

页数：2

共 13 条

[1] Towards a genomic-based diagnosis [J].

Brugarolas, J ;

Haynes, BF ;

Nevins, JR .

LANCET, 2001, 357 (9252) :249-250

[2] Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations [J].

Coussens, LM ;

Fingleton, B ;

Matrisian, LM .

SCIENCE, 2002, 295 (5564) :2387-2392

[3] INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].

DALEY, GQ ;

VANETTEN, RA ;

BALTIMORE, D .

SCIENCE, 1990, 247 (4944) :824-830

[4] Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (ST1571) [J].

Demetri, GD .

EUROPEAN JOURNAL OF CANCER, 2002, 38 :S52-S59

[5] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].

Druker, BJ ;

Tamura, S ;

Buchdunger, E ;

Ohno, S ;

Segal, GM ;

Fanning, S ;

Zimmermann, J ;

Lydon, NB .

NATURE MEDICINE, 1996, 2 (05) :561-566

[6] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[7] Creation of human tumour cells with defined genetic elements [J].

Hahn, WC ;

Counter, CM ;

Lundberg, AS ;

Beijersbergen, RL ;

Brooks, MW ;

Weinberg, RA .

NATURE, 1999, 400 (6743) :464-468

[8] ACUTE-LEUKEMIA IN BCR/ABL TRANSGENIC MICE [J].

HEISTERKAMP, N ;

JENSTER, G ;

TENHOEVE, J ;

ZOVICH, D ;

PATTENGALE, PK ;

GROFFEN, J .

NATURE, 1990, 344 (6263) :251-253

[9] INDUCTION OF A CHRONIC MYELOGENOUS LEUKEMIA-LIKE SYNDROME IN MICE WITH V-ABL AND BCR/ABL [J].

KELLIHER, MA ;

MCLAUGHLIN, J ;

WITTE, ON ;

ROSENBERG, N .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6649-6653

[10] In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor [J].

le Coutre, P ;

Mologni, L ;

Cleris, L ;

Marchesi, E ;

Buchdunger, E ;

Giardini, R ;

Formelli, F ;

Gambacorti-Passerini, C .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (02) :163-168

← 1 2 →